Cargando…
Diffuse skin hyperpigmentation in CD30+ lymphoproliferation
CD30+ T-cell lymphoproliferative disorders (LD) comprise two main groups of diseases: CD30+ LD of the skin and systemic anaplastic large cell lymphoma (ALCL). The main feature of these disorders is the expression of CD30. We present a patient with an unusual clinical presentation of CD30+ lymphoprol...
Autores principales: | Prka, Zeljko, Tomasovic-Loncaric, Cedna, Pejsa, Vlatko, Nevajda, Branimir, Kusec, Rajko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
King Faisal Specialist Hospital and Research Centre
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081047/ https://www.ncbi.nlm.nih.gov/pubmed/22588448 http://dx.doi.org/10.5144/0256-4947.2012.318 |
Ejemplares similares
-
Rituximab with dose-adjusted EPOCH as first-line treatment in patients with highly aggressive diffuse large B-cell lymphoma and autologous stem cell transplantation in selected patients
por: Pejša, Vlatko, et al.
Publicado: (2017) -
More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features
por: Lucijanic, Marko, et al.
Publicado: (2021) -
Diffuse Hyperpigmentation of the Skin in a Newborn
por: Anık, Ayşe, et al.
Publicado: (2022) -
Shear-wave sonoelastographic features of invasive lobular breast cancers
por: Brkljačić, Boris, et al.
Publicado: (2016) -
HCV and Lymphoproliferation
por: Zignego, Anna Linda, et al.
Publicado: (2012)